Recce Pharmaceuticals (STU:R9Q) Other Long-Term Liabilities : €0.16 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Recce Pharmaceuticals Other Long-Term Liabilities?

Recce Pharmaceuticals's other long-term liabilities for the quarter that ended in Dec. 2024 was €0.16 Mil.

Recce Pharmaceuticals's quarterly other long-term liabilities declined from Dec. 2023 (€0.13 Mil) to Jun. 2024 (€0.00 Mil) but then increased from Jun. 2024 (€0.00 Mil) to Dec. 2024 (€0.16 Mil).

Recce Pharmaceuticals's annual other long-term liabilities declined from Jun. 2022 (€0.00 Mil) to Jun. 2023 (€-0.00 Mil) but then increased from Jun. 2023 (€-0.00 Mil) to Jun. 2024 (€0.00 Mil).

Recce Pharmaceuticals Other Long-Term Liabilities Historical Data

The historical data trend for Recce Pharmaceuticals's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Recce Pharmaceuticals Other Long-Term Liabilities Chart

Recce Pharmaceuticals Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Other Long-Term Liabilities

Get a 7-Day Free Trial

Recce Pharmaceuticals Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Long-Term Liabilities	Get a 7-Day Free Trial													0.10	-	0.13	-	0.16

Recce Pharmaceuticals Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Recce Pharmaceuticals Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Recce Pharmaceuticals's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Recce Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Recce Pharmaceuticals Ltd (STU:R9Q) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

RECEF:USA RCE:Australia

Address

180 George Street, Level 23, Salesforce Tower, Sydney, NSW, AUS, 2000

Website

https://www.recce.com.au

Recce Pharmaceuticals Ltd is an Australia-based globally-focused biotechnology company engaged in the development and commercialization of a new class of antibiotics. The company operates in only one business segment being research and development of pharmaceutical drugs. The firm operates in three geographic segments being Australia, the United Kingdom, and the United States of America, of which the majority of the revenue comes from Australia. The company offers antibiotic drugs to treat diseases caused by various bacteria namely Sepsis, Neisseria gonorrhoeaei, Escherichia coli, Mycobacterium abscessus, and others.

Recce Pharmaceuticals Headlines

No Headlines